Читать книгу Gestational Diabetes - Группа авторов - Страница 16

1Laios K, Karamanou M, Saridaki Z, Androutsos G: Aretaeus of Cappadocia and the first description of diabetes. Hormones (Athens) 2012;11:109–113.

2Adams F: The Extant Works of Aretaeus the Cappadocian. London, Sydenham Society, 1856.

3Ahmed AM: History of diabetes mellitus. Saudi Med J 2002;23:373–378.

4Karamanou M, Protogerou A, Tsoucalas G, Androutsos G, Poulakou-Rebelakou E: Milestones in the history of diabetes mellitus: the main contributors. World J Diabetes 2016;7:1–7.

5Egan A, Dinneen S: What is diabetes? Medicine 2014;42:679–681.

6American Diabetes Association: 2. Classification and Diagnosis of Diabetes. Diabetes Care 2017;40(suppl 1):S11–S24.

7Eisenbarth GS: Update in type 1 diabetes. J Clin Endocrinol Metab 2007;92:2403–2407.

8Smushkin G, Vella A: What is type 2 diabetes? Medicine (Abingdon) 2010;38:597–601.

9Stride A, Hattersley AT: Different genes, different diabetes: lessons from maturity-onset diabetes of the young. Ann Med 2002;34:207–216.

10World Health Organization. Diagnostic Criteria and Classification of Hyperglycaemia First Detected in Pregnancy: A World Health Organization G, 2013. http://apps.who.int/iris/bitstream/10665/85975/1/WHO_NMH_MND_13.2_eng.pdf (accessed April 19, 2018).

11Duncan J: On peurperal diabetes. Trans Obstet Soc London 1882;24:256–285.

12Dunne FP, Gaffney G; Atlantic DI collaborators: The birth of ATLANTIC DIP: an overview. Ir Med J 2012;105(5 suppl):2–4.

13Cho NH, Shaw JE, Karuranga S, et al: IDF Diabetes Atlas: global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract 2018;138:271–281.

14International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care 2009;32:1327–1334.

15Report of the Expert Committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 1997;20:1183–1197.

16World Health Organization. Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications: Report of a WHO Consultation. Part 1: Diagnosis and Classification of Diabetes Mellitus. Geneva, World Health Organization, 1999.

17American Diabetes Association: Diagnosis and classification of diabetes mellitus. Diabetes Care 2010;33(suppl 1):S62–S69.

18World Health Organization. Use of Glycated Haemoglobin (HbA1c) in the Diagnosis of Diabetes Mellitus. Abbreviated Report of a WHO Consultation. Geneva, World Health Organization, 2011.

19National Institute for Health and Care Excellence. Type 1 Diabetes in Adults Overview, 2016. http://pathways.nice.org.uk/pathways/type-1-diabetes-in-adults (accessed April 19, 2018).

20Benhalima K, Mathieu C, Damm P, et al: A proposal for the use of uniform diagnostic criteria for gestational diabetes in Europe: an opinion paper by the European Board & College of Obstetrics and Gynaecology (EBCOG). Diabetologia 2015;58:1422–1429.

21Metzger BE, Gabbe SG, Persson B, et al: International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care 2010;33:676–682.

22National Institute for Health and Care Excellence. Diabetes in Pregnancy: Management from Preconception to the Postnatal Period, 2015. https://www.nice.org.uk/guidance/ng3/resources/diabetes-in-pregnancy-management-from-preconception-to-the-postnatal-period-pdf-51038446021 (accessed April 19, 2018).

23American Diabetes Association: 13. Management of diabetes in pregnancy. Diabetes Care 2018;41(suppl 1):S137–S143.

24Blumer I, Hadar E, Hadden DR, et al: Diabetes and pregnancy: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2013;98:4227–4249.

25Hod M, Kapur A, Sacks DA, et al: The International Federation of Gynecology and Obstetrics (FIGO) Initiative on gestational diabetes mellitus: a pragmatic guide for diagnosis, management, and care. Int J Gynaecol Obstet 2015;131(suppl 3):S173–S211.

26Metzger BE, Lowe LP, Dyer AR, et al: Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 2008;358:1991–2002.

27Benhalima K, Damm P, Van Assche A, et al: Screening for gestational diabetes in Europe: where do we stand and how to move forward?: A scientific paper commissioned by the European Board & College of Obstetrics and Gynaecology (EBCOG). Eur J Obstet Gynecol Reprod Biol 2016;201:192–196.

28Carpenter MW, Coustan DR: Criteria for screening tests for gestational diabetes. Am J Obstet Gynecol 1982;144:768–773.

29Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. National Diabetes Data Group. Diabetes 1979;28:1039–1057.

30Jacklin PB, Maresh MJ, Patterson CC, et al: A cost-effectiveness comparison of the NICE 2015 and WHO 2013 diagnostic criteria for women with gestational diabetes with and without risk factors. BMJ Open 2017;7:e016621.

31Simmons D: Epidemiology of diabetes in pregnancy; in McCance D, Maresh M (eds): Practical Management of Diabetes in Pregnancy. London, Blackwell Publishing, 2010.

32Jonasson JM, Brismar K, Sparén P, et al: Fertility in women with type 1 diabetes: a population-based cohort study in Sweden. Diabetes Care 2007;30:2271–2276.

33Albrecht SS, Kuklina EV, Bansil P, et al: Diabetes trends among delivery hospitalizations in the U.S., 1994–2004. Diabetes Care 2010;33:768–773.

34Kim SY, England L, Wilson HG, Bish C, Satten GA, Dietz P: Percentage of gestational diabetes mellitus attributable to overweight and obesity. Am J Public Health 2010;100:1047–1052.

35Ng M, Fleming T, Robinson M, et al: Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2014;384:766–781.

36Correa A, Bardenheier B, Elixhauser A, Geiss LS, Gregg E: Trends in prevalence of diabetes among delivery hospitalizations, United States, 1993–2009. Matern Child Health J 2015;19:635–642.

37National Pregnancy in Diabetes Audit Report, 2016. https://files.digital.nhs.uk/publication/7/s/national_pregnancy_in_diabetes_2016_report.pdf (accessed April 19, 2018).

38Damm JA, Asbjörnsdóttir B, Callesen NF, et al: Diabetic nephropathy and microalbuminuria in pregnant women with type 1 and type 2 diabetes: prevalence, antihypertensive strategy, and pregnancy outcome. Diabetes Care 2013;36:3489–3494.

39Ekbom P, Damm P, Feldt-Rasmussen B, Feldt-Rasmussen U, Mølvig J, Mathiesen ER: Pregnancy outcome in type 1 diabetic women with microalbuminuria. Diabetes Care 2001;24:1739–1744.

40Maahs DM, Snively BM, Bell RA, et al: Higher prevalence of elevated albumin excretion in youth with type 2 than type 1 diabetes: the SEARCH for Diabetes in Youth study. Diabetes Care 2007;30:2593–2598.

41Vestgaard M, Ringholm L, Laugesen CS, Rasmussen KL, Damm P, Mathiesen ER: Pregnancy-induced sight-threatening diabetic retinopathy in women with type 1 diabetes. Diabet Med 2010;27:431–435.

42Egan AM, McVicker L, Heerey A, Carmody L, Harney F, Dunne FP: Diabetic retinopathy in pregnancy: a population-based study of women with pregestational diabetes. J Diabetes Res 2015;2015:310239.

43Chakera AJ, Spyer G, Vincent N, Ellard S, Hattersley AT, Dunne FP: The 0.1% of the population with glucokinase monogenic diabetes can be recognized by clinical characteristics in pregnancy: the Atlantic Diabetes in Pregnancy cohort. Diabetes Care 2014;37:1230–1236.

44Reynaud Q, Poupon-Bourdy S, Rabilloud M, et al: Pregnancy outcome in women with cystic fibrosis-related diabetes. Acta Obstet Gynecol Scand 2017;96:1223–1227.

45Goss CH, VanDevanter DR: CFTR modulators and pregnancy: Our work has only just begun. J Cyst Fibros 2016;15:6–7.

46Benhalima K, Mathieu C, Van Assche A, et al: Survey by the European Board and College of Obstetrics and Gynaecology on screening for gestational diabetes in Europe. Eur J Obstet Gynecol Reprod Biol 2016;201:197–202.

47Lind T, Phillips PR: Influence of pregnancy on the 75-g OGTT. A prospective multicenter study. The Diabetic Pregnancy Study Group of the European Association for the Study of Diabetes. Diabetes 1991;40(suppl 2):8–13.

48Buckley BS, Harreiter J, Damm P, et al: Gestational diabetes mellitus in Europe: prevalence, current screening practice and barriers to screening. A review. Diabet Med 2012;29:844–854.

49O’Sullivan EP, Avalos G, O’Reilly M, et al: Atlantic Diabetes in Pregnancy (DIP): the prevalence and outcomes of gestational diabetes mellitus using new diagnostic criteria. Diabetologia 2011;54:1670–1675.

50DeSisto CL, Kim SY, Sharma AJ: Prevalence estimates of gestational diabetes mellitus in the United States, Pregnancy Risk Assessment Monitoring System (PRAMS), 2007–2010. Prev Chronic Dis 2014;11:E104.

51Sacks DA, Hadden DR, Maresh M, et al: Frequency of gestational diabetes mellitus at collaborating centers based on IADPSG consensus panel-recommended criteria: the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study. Diabetes Care 2012;35:526–528.

52Martin JA, Hamilton BE, Sutton PD, Ventura SJ, Menacker F, Kirmeyer S: Births: final data for 2004. Natl Vital Stat Rep 2006;55:1–101.

53Janevic T, Zeitlin J, Egorova N, Balbierz A, Howell EA: The role of obesity in the risk of gestational diabetes among immigrant and U.S.-born women in New York City. Ann Epidemiol 2018;28:242–248.

54Pickett KE, Wilkinson RG: People like us: ethnic group density effects on health. Ethn Health 2008;13:321–334.

55Janevic T, Borrell LN, Savitz DA, Echeverria SE, Rundle A: Ethnic enclaves and gestational diabetes among immigrant women in New York City. Soc Sci Med 2014;120:180–189.

56McIntyre HD, Sacks DA, Barbour LA, et al: Issues with the diagnosis and classification of hyperglycemia in early pregnancy. Diabetes Care 2016;39:53–54.

57Corrado F, D’Anna R, Cannata ML, Interdonato ML, Pintaudi B, Di Benedetto A: Correspondence between first-trimester fasting glycaemia, and oral glucose tolerance test in gestational diabetes diagnosis. Diabetes Metab 2012;38:458–461.

58Zhu WW, Yang HX, Wei YM, et al: Evaluation of the value of fasting plasma glucose in the first prenatal visit to diagnose gestational diabetes mellitus in china. Diabetes Care 2013;36:586–590.

59Harreiter J, Simmons D, Desoye G, et al: IADPSG and WHO 2013 gestational diabetes mellitus criteria identify obese women with marked insulin resistance in early pregnancy. Diabetes Care 2016;39:e90–e92.

60Egan AM, Vellinga A, Harreiter J, et al: Epidemiology of gestational diabetes mellitus according to IADPSG/WHO 2013 criteria among obese pregnant women in Europe. Diabetologia 2017;60:1913–1921.

61Reece EA, Leguizamón G, Wiznitzer A: Gestational diabetes: the need for a common ground. Lancet 2009;373:1789–1797.

62Egan AM, Danyliv A, Carmody L, Kirwan B, Dunne FP: A prepregnancy care program for women with diabetes: effective and cost saving. J Clin Endocrinol Metab 2016;101:1807–1815.

63Murphy HR, Roland JM, Skinner TC, et al: Effectiveness of a regional prepregnancy care program in women with type 1 and type 2 diabetes benefits beyond glycemic control. Diabetes Care 2010;33:2514–2520.

64Ghosh P, Luque-Fernandez MA, Vaidya A, et al: Plasma glycated CD59, a novel biomarker for detection of pregnancy-induced glucose intolerance. Diabetes Care 2017;40:981–984.

65Poston L, Bell R, Croker H, et al: Effect of a behavioural intervention in obese pregnant women (the UPBEAT study): a multicentre, randomised controlled trial. Lancet Diabetes Endocrinol 2015;3:767–777.

66Koivusalo SB, Rönö K, Klemetti MM, et al: Gestational diabetes mellitus can be prevented by lifestyle intervention: the Finnish gestational diabetes prevention study (RADIEL): a randomized controlled trial. Diabetes Care 2016;39:24–30.

67Simmons D, Devlieger R, van Assche A, et al: Effect of physical activity and/or healthy eating on GDM risk: the DALI lifestyle study. J Clin Endocrinol Metab 2017;102:903–913.

68Dodd JM, Turnbull D, McPhee AJ, et al: Antenatal lifestyle advice for women who are overweight or obese: LIMIT randomised trial. BMJ 2014;348:g1285.

69Shepherd E, Gomersall JC, Tieu J, Han S, Crowther CA, Middleton P: Combined diet and exercise interventions for preventing gestational diabetes mellitus. Cochrane Database Syst Rev 2017;11:CD010443.

70Chiswick C, Reynolds RM, Denison F, et al: Effect of metformin on maternal and fetal outcomes in obese pregnant women (EMPOWaR): a randomised, double-blind, placebo-controlled trial. Lancet Diabetes Endocrinol 2015;3:778–786.

71Syngelaki A, Nicolaides KH, Balani J, et al: Metformin versus placebo in obese pregnant women without diabetes mellitus. N Engl J Med 2016;374:434–443.

72Powe CE, Allard C, Battista MC, et al: Heterogeneous contribution of insulin sensitivity and secretion defects to gestational diabetes mellitus. Diabetes Care 2016;39:1052–1055.

Prof. Fidelma P. Dunne

Department of Medicine, Clinical Science Institute

National University of Ireland Galway

Newcastle, Galway H91 TK33 (Ireland)

E-Mail fidelma.dunne@nuigalway.ie